About EOS Iamging
EOS Iamging is a company based in Paris (France) founded in 1989 was acquired by ATEC Spine in February 2020. EOS Iamging has raised $43.8 million across 5 funding rounds from investors including Crédit Agricole, ATEC Spine and Fosun Pharmaceutical. EOS Iamging offers products and services including EOSedge, Advanced Orthopedic Solutions, and 3D Modeling. EOS Iamging operates in a competitive market with competitors including OXOS Medical, Scolioscan, Emerge Diagnostics, Aclarion and Knee Voice, among others.
- Headquarter Paris, France
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eos Imaging
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$43.8 M (USD)
in 5 rounds
-
Latest Funding Round
$17.07 M (USD), Post-IPO
Jul 17, 2018
-
Investors
Crédit Agricole
& 9 more
-
Employee Count
Not available
-
Acquired by
ATEC Spine
(Feb 28, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EOS Iamging
EOS Iamging offers a comprehensive portfolio of products and services, including EOSedge, Advanced Orthopedic Solutions, and 3D Modeling.
Provides advanced low-dose 2D/3D imaging for orthopedic applications
Offers tools for 3D measurements and surgical planning
Generates accurate 3D models from medical images for analysis
People of EOS Iamging
Unlock access to complete
Funding Insights of EOS Iamging
EOS Iamging has successfully raised a total of $43.8M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.07 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EOS Iamging
EOS Iamging has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Crédit Agricole, ATEC Spine and Fosun Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative financing is provided by IPF Partners for healthcare.
|
Locked | Locked | Locked | |
|
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for EOS Iamging
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EOS Iamging
Investment portfolio details for EOS Iamging
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EOS Iamging
Detailed financials for EOS Iamging
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eos Iamging Comparisons
Peer comparison for EOS Iamging
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EOS Iamging
EOS Iamging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OXOS Medical, Scolioscan, Emerge Diagnostics, Aclarion and Knee Voice, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Orthopedic imaging devices and software are developed for surgical use.
|
|
| Locked | Locked | Locked |
Radiation-free 3D ultrasound scoliosis assessment is developed.
|
|
| Locked | Locked | Locked |
Soft tissue injuries are diagnosed via a specialized electrodiagnostic device.
|
|
| Locked | Locked | Locked |
SaaS-based radiology image analysis tools are provided for medical providers.
|
|
| Locked | Locked | Locked |
Knee health is monitored via a wearable device during activities.
|
Detailed competitors of EOS Iamging
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eos Iamging
Complete news archive for EOS Iamging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EOS Iamging
EOS Iamging was founded in 1989 and raised its 1st funding round 16 years after it was founded.
EOS Iamging is headquartered in Paris, France.
EOS Iamging is a funded company, having raised a total of $43.8M across 5 funding rounds to date.
Founded in 1989 and based in Paris, France, the company operates in the medical imaging sector. 2D3D orthopedic imaging systems are provided to generate precise skeletal images of patients in upright positions, with reduced radiation exposure. Software solutions are developed to support various aspects of orthopedic care, including diagnostics and treatment planning, for healthcare professionals worldwide.
EOS Iamging's top competitors include OXOS Medical, Aclarion and Scolioscan.
EOS Iamging offers EOSedge, Advanced Orthopedic Solutions, and 3D Modeling.
EOS Iamging has 10 investors. Key investors include Crédit Agricole, ATEC Spine, Fosun Pharmaceutical, Edmond de Rothschild, and IPF Partners.